Publication: 3071

Publication: 3071

Alliance A031201: A phase III trial of enzalutamide (ENZ) versus enzalutamide, abiraterone, and prednisone (ENZ/AAP) for metastatic castration resistant prostate cancer (mCRPC)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 37 (suppl) abstr 5008

Meeting Instance:: ASCO 2019
Year:: 2019
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: 3845

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Astellas
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180888 (SWOG)

Corr. Author:
Authors:: Michael J. Morris Glenn Heller Alan Bryce Andrew Armstrong Himisha Beltran Olwen Hahn Eric C. McGary Paul Mehan Bruce Roth Han Xiao Colleen Watt David Hillman Mary Ellen Taplin Charles J. Ryan Susan Halabi Eric Small

Networks:: CA824, HEARTLAND, KAISER, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NY016, MN022

Study: Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: